Roivant Sciences Ltd WT (ROIVW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIVW | AZN | AMGN | GILD | BMY |
| Company | Roivant Sciences Ltd WT | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.86 | 202.81 | 354.25 | 138.06 | 60.00 |
| High | 2.92 | 203.37 | 356.90 | 138.54 | 60.12 |
| Low | 2.75 | 201.61 | 350.94 | 136.06 | 59.29 |
| Latest | 2.75 | 201.82 | 352.28 | 136.52 | 59.44 |
| Change | -0.11 | -2.98 | -3.02 | -1.12 | -0.73 |
| % Change | -3.85% | -1.46% | -0.85% | -0.81% | -1.21% |
| Volume | 37,800 | 616,120 | 921,611 | 1,591,979 | 3,004,439 |
| 20-Day Average Volume | 201,870 | 1,838,768 | 2,401,994 | 5,192,482 | 9,667,966 |
| Previous Close | 2.86 | 204.80 | 355.30 | 137.64 | 60.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 197.80 | 350.02 | 138.70 | 59.00 |
| 20-Day Raw Stochastic | 39.13% | 78.44% | 67.44% | 28.47% | 53.33% |
| 20-Day Relative Strength | 49.75 | 54.83 | 47.95 | 43.32 | 51.91 |
| Weighted Alpha | +210.22 | +44.48 | +24.55 | +29.37 | +28.52 |
| Today's Opinion | 48% Buy | 88% Buy | 56% Buy | 40% Buy | 64% Buy |
| Previous Opinion | 96% Buy | 88% Buy | 56% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 88% Buy | 56% Buy | 56% Buy | 64% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.10% since 08/25/23 | -0.15% since 04/13/26 | +0.48% since 04/13/26 | -1.84% since 04/13/26 | +2.53% since 04/13/26 |
| Low | 2.75 on 09/01/23 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 136.06 on 04/20/26 | 57.22 on 04/15/26 |
| High | 2.93 on 08/31/23 | 205.30 on 04/17/26 | 356.69 on 04/17/26 | 141.40 on 04/14/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | -15.12% since 08/01/23 | +9.98% since 03/20/26 | +1.07% since 03/20/26 | -0.54% since 03/20/26 | +3.57% since 03/20/26 |
| Low | 2.57 on 08/17/23 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 3.21 on 08/02/23 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +30.95% since 06/01/23 | +12.26% since 01/20/26 | +6.19% since 01/20/26 | +9.94% since 01/20/26 | +9.79% since 01/20/26 |
| Low | 1.92 on 06/27/23 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 53.54 on 01/21/26 |
| High | 4.00 on 07/06/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +59.88% since 03/01/23 | +20.38% since 10/20/25 | +15.88% since 10/20/25 | +10.86% since 10/20/25 | +36.57% since 10/20/25 |
| Low | 1.23 on 03/23/23 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 4.00 on 07/06/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 317,625,952 | 191,750,080 | 170,841,792 | 122,851,192 |
| Shares Outstanding, K | N/A | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 29,050,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -171,980,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,999,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -265,891,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | N/A | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 06/04/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | N/A | 21.89 | 15.99 | 17.00 | 9.59 |